telehealth · regulated markets
What Are the Telehealth State Medical Board Rules for Creators
Steve-O's Wild Ride, a 1.96M YouTube podcast, has run 46 deals across BetterHelp, a virtual therapy company, and BlueChew, a men's ED telehealth brand, since 2020. A founder of a multi-state telehealth Rx brand messaged me last week asking if her California prescriber's license was exposed when Steve-O's audience skewed 40 percent outside her footprint. The 90-second answer was yes. The reason was a Texas Medical Board complaint pattern that has hit a similar brand twice this year.
Across the 3,536 BetterHelp deals and 196 BlueChew deals in our database, the same five state boards (California, New York, Texas, Florida, Illinois) generate most creator-content complaints. The spread tells a brand which audiences it can pay creators to reach without putting the prescriber license on a board's desk.
The five-state spread that matters
Five boards do most of the work. California Medical Board. New York Office of Professional Medical Conduct. Texas Medical Board. Florida Board of Medicine. Illinois Department of Financial and Professional Regulation.
The board polices the prescriber the brand pays. Not the creator. But the creator's words can trigger a complaint that lands on the prescriber's desk inside 30 days.
California and New York are the loudest. Texas issues first-contact letters fastest. Florida moves slowly but writes long letters. Illinois is the quiet outlier.
The FTC's $7 million order against Cerebral in 2024 showed how fast a federal regulator can move. State boards move at half that speed but cost the prescriber the license itself. Here is the state-board map we send brands before the first deal.
Five boards matter most.
Licensure rules across MD, NP, and PA models
Three prescriber tiers run the telehealth market. Each tier changes what a creator can safely say on camera.
Tier one is MD-led. Psychiatrists, primary care doctors. The prescriber carries full medical board authority. The creator script gets the widest latitude here. Talkiatry, a telehealth psychiatry brand, sits in this tier. We track 30 Talkiatry deals across 18 creators since May 2025, including Solaii, a 124K-sub channel that quotes $800 per 60-second slot.
Tier two is NP-led. Nurse practitioner. Scope-of-practice ceilings vary by state. Some states require physician collaboration that limits what a creator can imply. BlueChew runs this model.
Tier three is PA-led. Physician assistant, supervised. The supervising MD is on the hook for creator claims even when the PA never appears in the post.
Not sure which tier your prescriber sits in? The tier decides the script. We pull the prescriber-tier map for your brand from public license records and pair it to the creator language each state board will and will not allow. Two-day turnaround, free.
Talk to us about your prescriber tier →What is safe for a non-credentialed creator? "I tried this brand and here is what happened." No implied prescriber role. KevOnStage Studios, a 499K-sub channel, has run 24 BetterHelp and BlueChew deals since 2024 using this script.
What triggers a board review? "I recommend this medication for [condition]" from anyone without a license in the viewer's state. The lawyer cuts that line before the post ships. Here is the credential-by-script matrix we hand brands at kickoff.
Geography math on creator audiences
Audience geography is the gate. Not the creator's home state. Not the brand's headquarters.
The creator brings 100K monthly viewers. 60 percent map to states the prescriber is licensed in. The other 40 percent generate signups that route to a partner network or get politely rejected at intake.
Would a brand lose the deal if the creator's audience was 35 percent outside the prescriber's footprint? It depends on the model. A single-state telehealth Rx brand would. A 50-state brand like BetterHelp would not.
Most brands we work with hold the line at 70 percent in-footprint audience as the minimum book-the-creator gate.
The DEA extension of telemedicine flexibilities through 2026 kept the federal door open for controlled-substance prescribing. State boards did not extend in step. A creator post naming a controlled substance in a state without telehealth flexibility is a complaint waiting to land. Here is the audience-geography check we run before any signed deal.
- Scraped lists with no audience-geography filter
- Hashtag-only search that ignores prescriber footprint
- One-size-fits-all rosters sold by sub-count, not state coverage
We're struggling with brand recognition in Toronto, and we really need to educate the market about our personalized approach to healthcare.— Gail Findlay-Shirras, Harrison Healthcare · discovery callGet the audience-geography map, free →
The four archetypes brands pick from
Four creator archetypes map to telehealth deals. One of them is the trap most brands default to.
In-state only. The creator's audience sits in the same states the prescriber covers. Lowest board risk. Highest match rate. Hardest to find at scale.
Multi-state. The audience spans 5 to 20 states. The prescriber footprint covers a majority. Workable for regional brands with a named state list.
National Rx. The audience is 50-state. The prescriber footprint is 50-state. BetterHelp lives here. Crystal Park, a 54.4K-sub channel, has run 30 BetterHelp slots since 2024. This deal model scales but only for brands with the operating model to back it.
Cash pay. No Rx is prescribed through the brand at all. The creator can speak freely about the category. No prescriber license is on the line. Marek Health, a TRT and peptide clinic, has run 210 deals across 32 creators since January 2024, anchored by Mark Bell's Power Project at 20 deals. This is the escape hatch for brands that want creator volume without board exposure.
Pick the wrong archetype for your model and you pay the per-creator rate plus a board defense bill that runs $15K to $50K per complaint. Pick the right one and you pay the per-creator rate only.
Pick the archetype first.
The audit trail every board asks for
The first complaint lands. The board gives the brand 48 hours to produce evidence. The list is short and the same every time.
The contract showing brand-approved language. The final approved script. The FTC disclosure placement record, including #ad position and verbal disclosure timestamp. The audience-geography snapshot at time of post. The prescriber's licensure record in every state the post reached.
Each item produced in under 24 hours is one the board does not escalate. Each missing item widens the review.
The FTC Health Breach Notification Rule sets a 60-day notification window for telehealth apps after a breach. State boards run on a 30-day reply window for prescribers. The two clocks do not coordinate. A brand that has the audit trail filed before the first email goes out covers both.
FAQ
Which state medical boards actually police telehealth creator content?
Five boards do most of the work: California, New York, Texas, Florida, Illinois. Each polices the licensed prescriber the brand pays, not the creator directly. The creator's words can still trigger a complaint that lands on the prescriber's desk inside 30 days. California and New York are the loudest in our data. Illinois is the quiet outlier most brands miss.
Can a creator in one state promote a telehealth brand to viewers in another state?
Yes, but the creator's home state does not matter. The prescriber's state license footprint does. Audience geography decides which state boards can receive a complaint. Multi-state Rx brands need a board-by-board read before booking a national creator. The 70 percent in-footprint audience threshold is the working rule for brands we work with.
What creator content language triggers a state medical board review?
Four phrase types: implied diagnosis ("if you have anxiety, you need..."), guarantee of outcome ("this will cure..."), prescriber recommendation from a non-prescriber ("I recommend [Rx medication]"), off-label use claims. The board then asks for the contract, the approved script, the FTC disclosure record, the audience-geography snapshot, and the prescriber license map.
Where We Come In
Five state medical boards generate most of the creator-content complaints a telehealth brand we work with will ever see. The brand that maps audience geography to prescriber footprint before the first email goes out spends $0 on board defense per pilot. The brand that books a national creator on the wrong archetype absorbs $15K to $50K per complaint plus the prescriber's calendar time defending it.
We do the state-board map for you. The audience-geography breakdowns, prescriber-footprint records, and per-state enforcement patterns already live in our database for the 1,577 BetterHelp creators, 43 BlueChew creators, and 32 Marek Health creators we track. Speak with us when the next creator brief crosses three or more state lines and you want the prescriber license protected before the post ships.
Boards police the prescriber.
Reading loop
Frequently asked
Which state medical boards actually police telehealth creator content?
Five boards do most of the work. California, New York, Texas, Florida, and Illinois. Each board polices the prescriber the brand pays, not the creator. But the creator's words can trigger a complaint that lands on the prescriber's desk inside 30 days. California and New York are the loudest. Illinois is the quiet one most brands miss.
Can a creator in one state promote a telehealth brand to viewers in another state?
Yes, but the creator's home state does not matter. The prescriber's state license footprint does. Audience geography is what decides which state boards can take a complaint. Multi-state brands need a board-by-board read before booking a national creator. Most brands we work with hold the line at 70 percent in-footprint audience.
What creator content language triggers a state medical board review?
Four phrase types do it. Implied diagnosis. Guarantee of outcome. A non-prescriber recommending a prescription drug. Off-label use claims. The board then asks the brand for the contract, the approved script, the FTC disclosure record, the audience-geography snapshot, and the prescriber license map. Each missing item widens the review.
Next issue, every Monday
We found the best performing creators for May 25 → May 31.Hand-picked, not the same five names.
Plus the Influencer Advisory Consultant GPT.